For: | Sobhani N, Sirico M, Generali D, Zanconati F, Scaggiante B. Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancer. World J Clin Oncol 2020; 11(7): 450-463 [PMID: 32821651 DOI: 10.5306/wjco.v11.i7.450] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v11/i7/450.htm |
Number | Citing Articles |
1 |
Navid Sobhani, Alberto D’Angelo, Matteo Pittacolo, Giuseppina Mondani, Daniele Generali. Future AI Will Most Likely Predict Antibody-Drug Conjugate Response in Oncology: A Review and Expert Opinion. Cancers 2024; 16(17): 3089 doi: 10.3390/cancers16173089
|
2 |
András Telekes, Anna Horváth. The Role of Cell-Free DNA in Cancer Treatment Decision Making. Cancers 2022; 14(24): 6115 doi: 10.3390/cancers14246115
|
3 |
Fabrizio Fontana, Martina Anselmi, Patrizia Limonta. Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy. Cancer Letters 2022; 534: 215619 doi: 10.1016/j.canlet.2022.215619
|
4 |
Dongjie Xu, Kaili Di, Boyue Fan, Jie Wu, Xinrui Gu, Yifan Sun, Adeel Khan, Peng Li, Zhiyang Li. MicroRNAs in extracellular vesicles: Sorting mechanisms, diagnostic value, isolation, and detection technology. Frontiers in Bioengineering and Biotechnology 2022; 10 doi: 10.3389/fbioe.2022.948959
|
5 |
Richard Tancredi, Navid Sobhani, Martina Catalano, Giandomenico Roviello, Daniele Generali. Current Trends in Liquid Biopsy Tracking Resistance in Molecular Breast Cancer-Targeted Therapies. Genes 2025; 16(4): 443 doi: 10.3390/genes16040443
|
6 |
Mohammad Hadi Abbasian, Ali M. Ardekani, Navid Sobhani, Raheleh Roudi. The Role of Genomics and Proteomics in Lung Cancer Early Detection and Treatment. Cancers 2022; 14(20): 5144 doi: 10.3390/cancers14205144
|
7 |
Emilio Francesco Giunta, Laura Annaratone, Enrico Bollito, Francesco Porpiglia, Matteo Cereda, Giuseppe Luigi Banna, Alessandra Mosca, Caterina Marchiò, Pasquale Rescigno. Molecular Characterization of Prostate Cancers in the Precision Medicine Era. Cancers 2021; 13(19): 4771 doi: 10.3390/cancers13194771
|